Fundación Pública Gallega de Medicina Genómica
Centro de investigación
University of Amsterdam
Ámsterdam, HolandaPublicaciones en colaboración con investigadores/as de University of Amsterdam (12)
2023
-
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study
Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280
2022
-
Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility
Nature Genetics, Vol. 54, Núm. 9, pp. 1275-1283
2021
2020
-
Premorbid Adjustment and IQ in Patients with First-Episode Psychosis: A Multisite Case-Control Study of Their Relationship with Cannabis Use
Schizophrenia Bulletin, Vol. 46, Núm. 3, pp. 517-529
-
The EUropean Network of National Schizophrenia Networks Studying Gene–Environment Interactions (EU-GEI): Incidence and First-Episode Case–Control Programme
Social Psychiatry and Psychiatric Epidemiology, Vol. 55, Núm. 5, pp. 645-657
2019
-
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
Nature Communications, Vol. 10, Núm. 1
-
Assessing cross-national invariance of the Community Assessment of Psychic Experiences (CAPE)
Psychological Medicine, Vol. 49, Núm. 15, pp. 2600-2607
-
Identification of regulatory variants associated with genetic susceptibility to meningococcal disease
Scientific Reports, Vol. 9, Núm. 1
-
Plasma lipid profiles discriminate bacterial from viral infection in febrile children
Scientific Reports, Vol. 9, Núm. 1
-
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study
The Lancet Psychiatry, Vol. 6, Núm. 5, pp. 427-436
2018
-
Treated incidence of psychotic disorders in the multinational EU-GEI study
JAMA Psychiatry, Vol. 75, Núm. 1, pp. 36-46
2014
-
Identifying gene-environment interactions in schizophrenia: Contemporary challenges for integrated, large-scale investigations
Schizophrenia Bulletin, Vol. 40, Núm. 4, pp. 729-736